Rejuvenating American Healthcare

An Honest Debate

Authors

  • Peter J Pitts CMPI

DOI:

https://doi.org/10.5912/jcb1018

Abstract

The debate over overhauling the American healthcare system is stuck on hold and plagued by soundbites. It’s time to insert substance and science into the conversation. If we learn nothing else from the COVID-19 experience, it’s that when the entire healthcare ecosystem works together to solve a seemingly unsolvable problem (in this case broader access to innovative prescription drugs) … we can. Nothing less than the future of American healthcare is at stake. During his March 2022 State of the Union Address, President Biden suggested a policy of price controls through direct Medicare negotiation to lower the costs of prescription drugs. This approach has long been discussed in the abstract. Let’s examine the details and potential consequences of such a proposition more closely.

 

 

 

Downloads

Published

2022-04-29

Issue

Vol. 27 No. 1 (2022): Volume 27, Issue 1

Section

Commentary

License

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.